# An Unusual Case of Neuroendocrine Carcinoma of the Gastro-Esophageal Junction Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion

**Authors:** Asmita Kulshrestha, Deeksha Jawale, Ankit Sharma, Priyanka Bhoj, Amitabh Pandagle

PMC · DOI: 10.7759/cureus.79807 · Cureus · 2025-02-28

## TL;DR

A rare case of esophageal neuroendocrine carcinoma complicated by a hormone disorder is reported, highlighting the aggressive nature and poor prognosis of this cancer type.

## Contribution

This case report adds to the limited literature on esophageal neuroendocrine carcinoma complicated by SIADH, emphasizing diagnostic and therapeutic challenges.

## Key findings

- The patient had stage IV neuroendocrine carcinoma of the gastro-esophageal junction with liver metastasis.
- The patient developed SIADH during chemotherapy, which led to deterioration and death within a year of diagnosis.
- NECs of the esophagus are rare, aggressive, and have a worse prognosis compared to other esophageal cancers.

## Abstract

Cancers of the esophagus tend to be aggressive with a poor prognosis. Neuroendocrine carcinoma (NEC) of the esophagus is very rare and currently does not have any established treatment regimens. This is in part due to its rare prevalence. This case report presents an unusual case of distal esophageal NEC, which was complicated by liver metastasis and paraneoplastic syndrome.

A 56-year-old postmenopausal woman came with complaints of weight loss, pain in the epigastric region, and intermittent dysphagia to solids for three months. An endoscopy revealed a 2 cm x 1 cm ulceronodular lesion located at the gastroesophageal junction. The biopsy showed NEC on histological examination, and the immunohistochemistry was positive for multiple neuroendocrine markers. A positron emission tomography (PET) scan revealed a stage IV metastatic disease that had spread to the liver as well as gastrohepatic and peri-gastric lymph nodes.

Subsequently, the patient received palliative intent chemotherapy with Etoposide and Cisplatin for four cycles, which resulted in a partial response. Due to this, she was advised four more cycles of chemotherapy, but after two cycles, she developed signs of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Following management with hypertonic saline, her health deteriorated, resulting in death within one year of diagnosis.

NECs of the esophagus tend to be detected at later stages and show a worse prognosis and disease course than squamous cell carcinoma or adenocarcinoma of the esophagus. With improvements in investigation methods, an increase in the detection of NEC in the esophagus can be expected in the future. Early diagnosis can help overall survival and boost quality of life. Further research and clinical trials are needed to assess ideal treatment plans.

## Linked entities

- **Chemicals:** Etoposide (PubChem CID 36462), Cisplatin (PubChem CID 5460033)
- **Diseases:** Neuroendocrine Carcinoma (MONDO:0002120)

## Full-text entities

- **Diseases:** dysphagia (MESH:D003680), pain (MESH:D010146), liver metastasis (MESH:D009362), NEC (MESH:D018278), adenocarcinoma of the esophagus (MESH:C562730), Cancers of the esophagus (MESH:D004938), death (MESH:D003643), SIADH (MESH:D007177), squamous cell carcinoma (MESH:D002294), weight loss (MESH:D015431), paraneoplastic syndrome (MESH:D010257)
- **Chemicals:** Etoposide (MESH:D005047), Cisplatin (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11955082/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11955082/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC11955082/full.md

---
Source: https://tomesphere.com/paper/PMC11955082